Dongcheng Pharmaceutical announced that Shanxiandike Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Andike, has received a “Radiopharmaceutical Production License” issued by the Shanxi Drug Administration, and the Shanxi Jinzhong Nuclear Drug Production Center has been approved for operation. The drug is a fluorine [F] deoxyglucose injection. The commissioning of the center will help Andeco develop markets, increase revenue, and improve the network layout of nuclear drugs across the country.

Zhitongcaijing · 2d ago
Dongcheng Pharmaceutical announced that Shanxiandike Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Andike, has received a “Radiopharmaceutical Production License” issued by the Shanxi Drug Administration, and the Shanxi Jinzhong Nuclear Drug Production Center has been approved for operation. The drug is a fluorine [F] deoxyglucose injection. The commissioning of the center will help Andeco develop markets, increase revenue, and improve the network layout of nuclear drugs across the country.